Cardiovascular disease is the number one cause of death of both men and women in the US; very often the first symptom is sudden death; stroke is also a major cause of disability and death in the US; one stroke related death occurs every 3 minutes, and African Americans are twice as likely to have a heart attack or a stroke.
The Metabolic Heart Health Program is carefully designed to evaluate well known risk factors associated with atherosclerosis and cardiovascular disease such as high cholesterol and high blood pressure. In addition, less known but more important risk factors such as heavy metals, inflammatory markers and the omega 3 index are also evaluated.
The Omega 3 Index may be the most important number for heart health. It measures the concentration of the Omega 3s, EPA and DHA, as a percent of total fatty acids in red blood cells, and is a very strong predictor of the risk of heart disease – especially the risk of dying from a sudden heart attack which contributes to over half of deaths associated with heart disease.
Information on arterial wall stiffness through Digital Pulsewave Analysis (DPA) is an integral part of the Metabolic Heart Assessment. The DPA provides information on arterial wall stiffness and determines the biological age of arteries in less than 3 minutes. This FDA approved, user-friendly, non-invasive device uses a finger probe to observe the changes in pressure, blood flow, velocity and profile throughout the whole pulse wave. Finally, hormone levels are tested to achieve a comprehensive evaluation of cardiovascular status. Low testosterone levels and high estrogen levels have been linked to heart disease in men, and testosterone replacement therapy has been shown to be cardio protective especially in men who are also diabetic.
All traditional and non-traditional risk factors should be addressed as an overall heart health risk reduction strategy.
For clients who are found to be at moderate to high risk of coronary disease, carotid artery ultrasound will be done for therapeutic endpoint management.
Over 50% of heart attack patients have optimal cholesterol levels, so it is clear that a more in-depth look at a patient’s risk of heart attack is needed.
The Screening for Heart Attack Prevention and Education (SHAPE) Task Force presents a new practice guideline for cardiovascular screening in the asymptomatic at-risk population. SHAPE Guideline calls for noninvasive screening to detect and treat those with subclinical atherosclerosis.
The Metabolic Heart Health Program incorporates SHAPE guidelines and is the best strategy for prevention, early detection and therapeutic intervention to prevent premature death from heart disease or stroke. Lifestyle recommendations, targeted nutritional supplements, and bioidentical hormones will be recommended based on the findings, as well as carefully chosen prescription medicines, if deemed necessary.